Intrinsiqq
Lexeo Therapeutics Inc. logo

Lexeo Therapeutics Inc. Intrinsic Value

LXEO

Compare

Lexeo Therapeutics fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Lexeo Therapeutics today, so there is nothing to project yet.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with LXEO

CompareIntrinsic value
CRDFCardiff Oncology Inc.
$0.85-4.18%36
PROKProKidney Corp
$1.04-1.89%10
IMAImageneBio, Inc.
$3.92-1.51%10
PALIPalisade Bio Inc.
$0.84-9.69%20
CMPXCompass Therapeutics Inc.
$0.69+1.40%10
ARMPArmata Pharmaceuticals Inc.
$3.03+1.68%30
BCABBioAtla, Inc.
$1.55+20.16%0
CVMCel-Sci Corporation
$1.21-17.69%0

Held by ETFs

LXEO is in 14 US ETFs. The largest of them, with LXEO's weight in each:

Spot a number that looks wrong? Check it in LXEO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing LXEO

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.